| |
| |
|
| Insider
Information: |
Stapleton Craig R |
| Relationship: |
Former 10% Owner |
| City: |
Greenwich |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
812,271 |
|
|
Indirect Shares
|
2,658,665 |
|
|
| Direct
Value |
$13,055,014 |
|
|
|
Indirect Value
|
$312,394,399 |
|
|
| Total
Shares |
3,470,936 |
|
|
| Total
Value |
$325,449,413 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sonomawest Holdings Inc |
SWHI |
See Remarks, Director,... |
2009-02-20 |
376,645 |
2011-06-23 |
550,601 |
Premium* |
|
|
T-Mobile Us Inc |
TMUS |
Director |
|
0 |
2004-07-28 |
1,864,800 |
Premium* |
|
|
Abercrombie & Fitch Co |
ANF |
Director |
2016-09-01 |
57,398 |
2010-02-18 |
0 |
Premium* |
|
|
AVADEL Pharmaceuticals Plc |
AVDL |
Director |
2018-08-01 |
378,228 |
2018-08-01 |
210,400 |
Premium* |
|
|
Reata Pharmaceuticals Inc |
RETA |
Former 10% Owner |
2016-06-09 |
0 |
2016-06-09 |
32,864 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
54 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ANF |
Abercrombie & Fitch Co |
Director |
– • – |
2010-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
0 |
- |
|
| ANF |
Abercrombie & Fitch Co |
Director |
– • – |
2010-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,398 |
7,398 |
0 |
- |
|
| ANF |
Abercrombie & Fitch Co |
Director |
– • – |
2010-08-20 |
4 |
B |
$35.51 |
$262,703 |
D/D |
7,398 |
14,796 |
2.39 |
- |
|
| ANF |
Abercrombie & Fitch Co |
Director |
– • – |
2011-09-20 |
4 |
S |
$69.70 |
$515,641 |
D/D |
(7,398) |
7,398 |
0 |
- |
|
| ANF |
Abercrombie & Fitch Co |
Director |
– • – |
2012-05-22 |
4 |
B |
$35.43 |
$354,295 |
D/D |
10,000 |
17,398 |
2.39 |
- |
|
| ANF |
Abercrombie & Fitch Co |
Director |
• • – |
2013-06-25 |
4 |
B |
$43.98 |
$440,150 |
D/D |
10,000 |
27,398 |
2.39 |
- |
|
| ANF |
Abercrombie & Fitch Co |
Director |
• • – |
2014-05-30 |
4 |
B |
$37.30 |
$373,000 |
D/D |
10,000 |
37,398 |
2.39 |
- |
|
| ANF |
Abercrombie & Fitch Co |
Director |
• • – |
2015-06-22 |
4 |
B |
$22.42 |
$224,200 |
D/D |
10,000 |
47,398 |
2.39 |
- |
|
| ANF |
Abercrombie & Fitch Co |
Director |
• • – |
2016-09-01 |
4 |
B |
$17.65 |
$176,500 |
D/D |
10,000 |
57,398 |
2.39 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2016-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
382,450 |
|
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2016-03-14 |
4 |
B |
$10.39 |
$1,039,400 |
D/D |
100,000 |
482,450 |
2.39 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2016-05-13 |
4 |
B |
$9.21 |
$228,553 |
D/D |
24,813 |
507,263 |
2.39 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2016-05-16 |
4 |
B |
$9.25 |
$22,339 |
D/D |
2,415 |
509,678 |
2.39 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2016-08-26 |
4 |
B |
$13.67 |
$275,140 |
I/I |
20,000 |
20,000 |
2.1 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2016-09-01 |
4 |
B |
$13.52 |
$135,190 |
D/D |
10,000 |
519,678 |
2.39 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2016-11-28 |
4 |
B |
$10.74 |
$107,370 |
I/I |
10,000 |
30,000 |
2.1 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2016-11-29 |
4 |
B |
$10.85 |
$108,500 |
I/I |
10,000 |
40,000 |
2.1 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2016-12-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
27,000 |
492,678 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2016-12-19 |
4 |
GA |
$0.00 |
$0 |
I/I |
29,700 |
16,200 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2016-12-19 |
4 |
GD |
$0.00 |
$0 |
I/I |
13,500 |
26,500 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2016-12-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(56,200) |
0 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2016-12-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(492,678) |
0 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2017-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
492,678 |
492,678 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2017-01-03 |
4 |
A |
$0.00 |
$0 |
I/I |
56,200 |
16,200 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2017-04-04 |
4 |
A |
$9.58 |
$143,643 |
D/D |
15,000 |
507,678 |
0 |
- |
|
54 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
